Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
354 participants
OBSERVATIONAL
2021-05-21
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
HPVAC2 is a prospective, analytic and monocentric study designed to learn the impact of the catch-up HPV vaccination.
Women from 25 years old and born after 1984 may be included if they come to the Brest CHU to do their regular cervical smear. At this time, a survey will be given to know their vaccinal status.
The aim of the study is to prove the efficacy of the catch up vaccination by analyzing the cervical smears results and by comparing the vaccinated group with the not-vaccinated group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of HPV Vaccination to Catch up in the Emergence of Lesions of the Cervix
NCT03328013
Impact of HPV Vaccination on Cervical High Grade Lesions in France
NCT04167501
CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas
NCT02981862
Agreement Between Oral and Cervical Human Papillomavirus Infection in a French Cohort
NCT02774538
Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination in Integrated Healthcare Delivery Systems
NCT03887793
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vaccinated
Patients who have been vaccinated against HPV virus.
No interventions assigned to this group
Not vaccinated
Patients who have not been vaccinated against HPV virus.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient must have done a HPV or smear test during the study period
* Consent necessary
Exclusion Criteria
* No HPV or smear test done in the study period
* Patient not able to give her consent
25 Years
38 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philippe MERVIEL, PU-PH
Role: STUDY_DIRECTOR
Head of the gynecologic department in Brest Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de BREST
Brest, Finistère, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HPVAC2 - 29BRC21.0008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.